H.U. Group Holdings, Inc. (TYO:4544)
Japan · Delayed Price · Currency is JPY 3,213.00
-29.00 (-0.89%)
At close: Feb 6, 2026
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 63.00B JPY in the quarter ending September 30, 2025, with 4.09% growth. This brings the company's revenue in the last twelve months to 247.43B, up 2.93% year-over-year. In the fiscal year ending March 31, 2025, H.U. Group Holdings had annual revenue of 243.03B with 2.56% growth.
Revenue (ttm)
247.43B
Revenue Growth
+2.93%
P/S Ratio
0.72
Revenue / Employee
45.45M
Employees
5,444
Market Cap
178.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
| Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
| Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
| Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
| Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Daiichi Sankyo Company | 2.05T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Towa Pharmaceutical | 266.67B |
| AS ONE | 107.59B |
| Paramount Bed Holdings | 107.03B |
| Kissei Pharmaceutical | 95.29B |